The Scientific Validity of Adverse Events from Schedule of Controlled Substances: C= 100-1/2n

This study provides biological, epidemiological, clinical and mathematical evidence to suggest with % 99.994 certainty that “Schedule of controlled substances“has adverse effects expressed as an equation C=1001/2n (with “C “ representing certainty and “n “ as the number of supporting evidence). This observation Is consistent with mathematical principals and with the butterfly effect of sensitive dependence of complex systems on initial minor errors. SCS adverse effects include creation of barriers to appropriate treatment and research of chronic pain, addictions and psychiatric disorders, reducing the number of potential medical discoveries, contribution to Inappropriate therapeutic interventions for people with chronic pain addictions and psychiatric disorders, contribution to premature death by barriers to appropriate treatment of chronic pain, addictions and psychiatric disorders. Table 1: Schedule of controlled substances. Schedule Description Representative Substances I. Substances that have no Accepted medicals use in the U.S. and have high abuse potential Heroin, LSD, mescaline, marijuana, THC, MDMA II. Substances that have high abuse potential with sever psychic or physical dependency liability Opium, morphine, codeine, meperidine (Demerol), cocaine, amphetamine, methylphenidate (Retalin), pentobarbital, phencyclidine (PCP) III. Substances that have an abuse potential less than those in schedules 1 and 2, including compounds containing limited quantities of certain narcotic and nonnarcotic drugs Paregoric, barbiturates other those listed in another schedule IV. Substances that have an abuse potential less than those in schedule 3. Phenobarbital, chloral hydrate, diazepam (Valium), alprazolam (Xanax) V. Substances that have an abuse potential less than those in schedule 4, consisting of preparations containing limited amounts of certain narcotic drugs generally for antitussive (cough suppressant) and antidiarrheal purposes Although it has been recognized that SCS lacks scientific validity no studies have investigated potential adverse effects of SCS. SCS does not have a scientifically valid inclusion or exclusion criteria, does not indicate why alcohol and tobacco are excluded [1,2]. SCS is dismissive of pharmacodynamics, pharmacokinetics and biological markers such as half-life elimination time, latency, euphoric potency. Examples include Inclusion of marijuana and cocaine in class one [1,2]. SCS is dismissive of route of administration (by mouth, skin, air, intramuscular or intravenous injection). For instance, methylphenidate oral tablets are fundamentally different than methylphenidate slow release tablets which have potentially no overuse or addictive potency [1,2]. Absence of consideration of risk versus benefits is transparent in the inclusion of marijuana in schedule 1 despite its documented therapeutic benefits [1,2]. Biomedical Journal of Scientific & Technical Research Volume 7Issue 4: 2018 Cite this article: Alen J Salerian. The Scientific Validity of Adverse Events from Schedule of Controlled Substances: C= 100-1/2n. Biomed J Sci&Tech Res 7(4)2018. BJSTR. MS.ID. 001528. DOI: 10.26717/ BJSTR.2018. 07.001528. 5996 Diverse biological epidemiological and clinical evidence suggest untreated chronic pain, treatment refractory depression, substance addictions are associated with premature death [18]. There’s also compelling neuro imaging evidence of brain degeneration and atrophy caused by chronic pain [6]. Some studies suggest a strikingly high mortality associated with discontinuation of opiates among patients with heroin addiction [7-11]. This study investigated potential adverse effects of SCS on chronic pain. Methods We reviewed vital statistics from 2000-2014 we also reviewed relevant medical literature on medication treatment of chronic pain, substance addiction, treatment refractory depression. Inclusion criteria included studies with methadone, buprenorphine, oxycodone published between 2000 and 2017 in English. Adverse influences of SCS are Creation of barriers to appropriate treatment of chronic pain, addictions and psychiatric disorders. Barriers, in this context, are defined as influences that delay, discourage or diminish the most effective delivery of appropriate medical care [1,2,11-13]. For instance, consumer friendly an efficient treatment of various psychiatric disorders, chronic pain and addictions have been adversely influenced by man-made barriers, such as a special rules and regulations governing controlled substances. The examples include, special requirements to receive or prescribe commonly used medications such as methadone, buprenorphine or methylphenidate [1,2]. a) Creation of barriers to medical research and reducing the number of potential medical discoveries [1,2,12]. b) Contribution to promotion of Inappropriate therapeutic interventions for people with chronic pain addictions and psychiatric disorders [1,2,4,12]. Indirectly or unintentionally, SCS contribute to irrational unscientific information about brain dysfunctions and therefore promotes several treatments such as alcoholics Anonymous and narcotics anonymous that strongly advocate against all biological interventions for people with chronic pain, psychiatric disorders or addictions [1,2,4,12]. c) Contribution to premature death by barriers to appropriate treatment of chronic pain, addictions and psychiatric disorders. Cumulative evidence is consistent with the observation that less than optimal treatment of chronic pain addictions and psychiatric disorders contributed to higher mortality and morbidity [7-12]. d) Contribution to premature brain degeneration by barriers to appropriate treatment of chronic pain, addictions and psychiatric disorders. There is considerable evidence consistent with the observation that chronic pain and various psychiatric disorders are associated with premature brain degeneration and atrophy demonstrable by neuroimaging [1-12]. e) Contribution to irrational criminal prosecution of innocent patients with chronic pain, addictions and psychiatric disorders and their doctors [12-15]. f) Contribution to restricting the number of health professionals treating chronic pain, addictions and psychiatric disorders and their doctors [1,2,12-15]. g) Contribution to epidemics of deaths from suicide and heroin overdose [10-12] h) Promotion of prejudice against people in need of substances wrongly classified as addictive or harmful [12-15]. i) Promotion of laws and regulations hostile to people with chronic pain, addiction and psychiatric disorders [12-15]. j) Contribution to adverse influence on how vital data are registered. k) Collection of recorded reported data of fatalities from overdose deaths misrepresent the number of deaths caused by controlled substances For Two Independent Reasons SCS is not scientifically valid and has an influence over how data are registered. The reported cause of death is often made without a causal link between death and toxic influence -validated by a Laboratory evidence-of a substance. Hey, hon and well documented practice is to declare any death associated with presence of any controlled substance regardless of its blood level-as caused by an overdose of the very substance found in the system. This means, any controlled substance would along half-life is a far greater chance of being declared as the final lethal cause. a) Contribution to inaccurate vital statistics of deaths associated with drugs. b) Contribution to promotion of irrational laws adversely influencing quality-of-life for people which chronic pain addictions and restrictions [12,13,14,15]. c) Contribution to increased mortality and morbidity associated with alcohol and tobacco use. This equation is based upon the premise that each supporting evidence is a hypothesis. A logical inference from observing facts from which consequences may be deduced with a % 50 chance of being correct and therefore the outcome would be the same as the probability of random occurrence in flipping a coin. Hence it would be like “ heads “coming up a consecutive number “n “ of times. For instance , the probability of“ heads “ coming up 3 consecutive times is 1/8 or 11%, five consecutive times is 3%, 10 consecutive times is % 0.09 of crucial significance, consistent with the framework of flipping a coin, potential flaws of statistical analysis randomness and biashave no effect on the accuracy of final outcome. This equation is also based upon the presumption that each evidence is scientifically valid (Thus any evidence contrary to a supporting evidence would exponentially decrease the final outcome by the same number of errors) (Table 2). Biomedical Journal of Scientific & Technical Research Volume 7Issue 4: 2018 Cite this article: Alen J Salerian. The Scientific Validity of Adverse Events from Schedule of Controlled Substances: C= 100-1/2n. Biomed J Sci&Tech Res 7(4)2018. BJSTR. MS.ID. 001528. DOI: 10.26717/ BJSTR.2018. 07.001528. 5997 Table 2: The probability of certainty in SCS induced adverse effects consistent with C= 100-1/2n=%99.994. 1. Creation of barriers to appropriate treatment of chronic pain, addictions and psychiatric disorders. Creation of barriers to medical research and reducing the number of potential medical discoveries. Inappropriate therapeutic interventions for people with chronic pain addictions and psychiatric disorders. Contribution to premature death by barriers to appropriate treatment of chronic pain, addictions and psychiatric disorders. Contribution to premature brain degeneration by barriers to appropriate treatment of chronic pain, addictions and psychiatric disorders. Contribution to irrational criminal prosecution of innocent patients with chronic pain, addictions and psychiatric disorders and their doctors. Contribution to restricting the number of health professionals treating chronic pain, addictions and psychiatric disorders and their doctors. Contribution to epidemics of deaths from sui